Chronic olanzapine treatment decreases arachidonic acid turnover and prostaglandin E 2 concentration in rat brain

Journal of Neurochemistry

Volumn 119, Issue 2, 2011, Pages 364-376

  Cheon, Yewon ^a   Park, Jee Young ^a   Modi, Hiren R ^a   Kim, Hyung Wook ^a   Lee, Ho Joo ^a   Chang, Lisa ^a   Rao, Jagadeesh S ^a   Rapoport, Stanley I ^a  

^a NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

anti psychotic; bipolar disorder; cyclooxygenase; phospholipid; prostaglandin E 2; washout

Indexed keywords

ARACHIDONIC ACID; CHOLESTEROL; CHOLESTEROL ESTER; FATTY ACID; MESSENGER RNA; OLANZAPINE; OMEGA 3 FATTY ACID; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLETHANOLAMINE; PHOSPHATIDYLINOSITOL; PHOSPHATIDYLSERINE; PHOSPHOLIPID; PROSTAGLANDIN E2; PROSTAGLANDIN SYNTHASE; TRIACYLGLYCEROL;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BLOOD SAMPLING; BODY TEMPERATURE; BODY WEIGHT; CONTROLLED STUDY; ENZYME ACTIVITY; HEART RATE; MEAN ARTERIAL PRESSURE; NONHUMAN; PHYSICAL PARAMETERS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; UPREGULATION;

ACYL COENZYME A; ALGORITHMS; ANIMALS; ANTIPSYCHOTIC AGENTS; ARACHIDONIC ACID; BENZODIAZEPINES; BLOOD PRESSURE; BLOTTING, WESTERN; BODY WEIGHT; BRAIN CHEMISTRY; CHOLINE; CHROMATOGRAPHY, GAS; CYTOSOL; DINOPROSTONE; HALF-LIFE; HEART RATE; KINETICS; LIPID METABOLISM; MALE; PHOSPHOLIPASES A2; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RATS; RATS, INBRED F344; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

RATTUS;

EID: 80053570242     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2011.07410.x     Document Type: Article

References (86)

1. Albaugh V. L., Vary T. C., Ilkayeva O., et al. (2010) Atypical antipsychotics rapidly and inappropriately switch peripheral fuel utilization to lipids, impairing metabolic flexibility in rodents. Schizophr. Bull. Published Online doi: 10.1093/schbul/sbq053.
2. Albaugh V. L., Judson J. G., She P., Lang C. H., Maresca K. P., Joyal J. L., and, Lynch C. J., (2011) Olanzapine promotes fat accumulation in male rats by decreasing physical activity, repartitioning energy and increasing adipose tissue lipogenesis while impairing lipolysis. Mol Psychiatry 16, 569-581.
3. Aravagiri M., Teper Y., and, Marder S. R., (1999) Pharmacokinetics and tissue distribution of olanzapine in rats. Biopharm. Drug Dispos. 20, 369-377. (Pubitemid 30449775)
4. Attarbaschi T., Sacher J., Geiss-Granadia T., et al. (2007) Striatal D(2) receptor occupancy in bipolar patients treated with olanzapine. Eur. Neuropsychopharmacol. 17, 102-107. (Pubitemid 44802834)
5. Bazan N. G., (2005) Lipid signaling in neural plasticity, brain repair, and neuroprotection. Mol. Neurobiol. 32, 89-103. (Pubitemid 41113211)
6. Bazinet R. P., Lee H. J., Felder C. C., Porter A. C., Rapoport S. I., and, Rosenberger T. A., (2005) Rapid high-energy microwave fixation is required to determine the anandamide (N-arachidonoylethanolamine) concentration of rat brain. Neurochem. Res. 30, 597-601. (Pubitemid 41185875)
7. Bazinet R. P., Rao J. S., Chang L., Rapoport S. I., and, Lee H. J., (2006) Chronic carbamazepine decreases the incorporation rate and turnover of arachidonic acid but not docosahexaenoic acid in brain phospholipids of the unanesthetized rat: relevance to bipolar disorder. Biol. Psychiatry 59, 401-407. (Pubitemid 43289218)
8. Belmaker R. H., (2004) Bipolar disorder. N. Engl. J. Med. 351, 476-486.
9. Berg K. A., Maayani S., Goldfarb J., Scaramellini C., Leff P., and, Clarke W. P., (1998) Effector pathway-dependent relative efficacy at serotonin type 2A and 2C receptors: evidence for agonist-directed trafficking of receptor stimulus. Mol. Pharmacol. 54, 94-104. (Pubitemid 28337591)
10. Bezard J., Blond J. P., Bernard A., and, Clouet P., (1994) The metabolism and availability of essential fatty acids in animal and human tissues. Reprod. Nutr. Dev. 34, 539-568.
11. Bhattacharjee A. K., Meister L. M., Chang L., Bazinet R. P., White L., and, Rapoport S. I., (2007) In vivo imaging of disturbed pre- and post-synaptic dopaminergic signaling via arachidonic acid in a rat model of Parkinson's disease. Neuroimage 37, 1112-1121. (Pubitemid 47385277)
12. Bostwick J. M., and, Pankratz V. S., (2000) Affective disorders and suicide risk: a reexamination. Am. J. Psychiatry 157, 1925-1932.
13. Bymaster F. P., Calligaro D. O., Falcone J. F., Marsh R. D., Moore N. A., Tye N. C., Seeman P., and, Wong D. T., (1996) Radioreceptor binding profile of the atypical antipsychotic olanzapine. Neuropsychopharmacology 14, 87-96. (Pubitemid 26053226)
14. Calabrese J. R., Kimmel S. E., Woyshville M. J., Rapport D. J., Faust C. J., Thompson P. A., and, Meltzer H. Y., (1996) Clozapine for treatment-refractory mania. Am. J. Psychiatry 153, 759-764. (Pubitemid 26170535)
15. Chang M. C., Grange E., Rabin O., Bell J. M., Allen D. D., and, Rapoport S. I., (1996) Lithium decreases turnover of arachidonate in several brain phospholipids. Neurosci. Lett. 220, 171-174. (Pubitemid 27023604)
16. Chang M. C., Arai T., Freed L. M., et al. (1997) Brain incorporation of [1-11C]arachidonate in normocapnic and hypercapnic monkeys, measured with positron emission tomography. Brain Res. 755, 74-83. (Pubitemid 27192000)
17. Chang M. C., Contreras M. A., Rosenberger T. A., Rintala J. J., Bell J. M., and, Rapoport S. I., (2001) Chronic valproate treatment decreases the in vivo turnover of arachidonic acid in brain phospholipids: a possible common effect of mood stabilizers. J. Neurochem. 77, 796-803. (Pubitemid 32466776)
18. Cunnane S. C., Ryan M. A., Nadeau C. R., Bazinet R. P., Musa-Veloso K., and, McCloy U., (2003) Why is carbon from some polyunsaturates extensively recycled into lipid synthesis? Lipids 38, 477-484. (Pubitemid 36724309)
19. DeGeorge J. J., Noronha J. G., Bell J., Robinson P., and, Rapoport S. I., (1989) Intravenous injection of [1-14C]arachidonate to examine regional brain lipid metabolism in unanesthetized rats. J. Neurosci. Res. 24, 413-423. (Pubitemid 20001454)
20. DeGeorge J. J., Nariai T., Yamazaki S., Williams W. M., and, Rapoport S. I., (1991) Arecoline-stimulated brain incorporation of intravenously administered fatty acids in unanesthetized rats. J. Neurochem. 56, 352-355. (Pubitemid 21901971)
21. DeMar J. C., Jr, Ma K., Bell J. M., and, Rapoport S. I., (2004) Half-lives of docosahexaenoic acid in rat brain phospholipids are prolonged by 15 weeks of nutritional deprivation of n-3 polyunsaturated fatty acids. J. Neurochem. 91, 1125-1137. (Pubitemid 39587451)
22. Demar J. C., Jr, Ma K., Chang L., Bell J. M., and, Rapoport S. I., (2005) alpha-Linolenic acid does not contribute appreciably to docosahexaenoic acid within brain phospholipids of adult rats fed a diet enriched in docosahexaenoic acid. J. Neurochem. 94, 1063-1076. (Pubitemid 41170593)
23. DeMar J. C., Jr, Lee H. J., Ma K., Chang L., Bell J. M., Rapoport S. I., and, Bazinet R. P., (2006) Brain elongation of linoleic acid is a negligible source of the arachidonate in brain phospholipids of adult rats. Biochim. Biophys. Acta 1761, 1050-1059. (Pubitemid 44354290)
24. Dennis E. A., (1994) Diversity of group types, regulation, and function of phospholipase A2. J. Biol. Chem. 269, 13057-13060. (Pubitemid 24206060)
25. Deutsch J., Grange E., Rapoport S. I., and, Purdon A. D., (1994) Isolation and quantitation of long-chain acyl-coenzyme A esters in brain tissue by solid-phase extraction. Anal. Biochem. 220, 321-323. (Pubitemid 24261175)
26. Deutsch J., Rapoport S. I., and, Purdon A. D., (1997) Relation between free fatty acid and acyl-CoA concentrations in rat brain following decapitation. Neurochem. Res. 22, 759-765. (Pubitemid 27300632)
27. Ferno J., Vik-Mo A. O., Jassim G., et al. (2009) Acute clozapine exposure in vivo induces lipid accumulation and marked sequential changes in the expression of SREBP, PPAR, and LXR target genes in rat liver. Psychopharmacology (Berl) 203, 73-84.
28. Fitzpatrick F. A., and, Soberman R., (2001) Regulated formation of eicosanoids. J. Clin. Invest. 107, 1347-1351. (Pubitemid 32522026)
29. Folch J., Lees M., and, Sloane Stanley G. H., (1957) A simple method for the isolation and purification of total lipides from animal tissues. J. Biol. Chem. 226, 497-509.
30. Frangou S., Lewis M., and, McCrone P., (2006) Efficacy of ethyl-eicosapentaenoic acid in bipolar depression: randomised double-blind placebo-controlled study. Br. J. Psychiatry 188, 46-50. (Pubitemid 43021926)
31. Gao F., Kiesewetter D., Chang L., Rapoport S. I., and, Igarashi M., (2010) Quantifying conversion of linoleic to arachidonic and other n-6 polyunsaturated fatty acids in unanesthetized rats. J. Lipid Res. 51, 2940-2946.
32. Ghelardoni S., Tomita Y. A., Bell J. M., Rapoport S. I., and, Bosetti F., (2004) Chronic carbamazepine selectively downregulates cytosolic phospholipase A2 expression and cyclooxygenase activity in rat brain. Biol. Psychiatry 56, 248-254. (Pubitemid 39092939)
33. Holman R. T., (1986) Control of polyunsaturated acids in tissue lipids. J. Am. Coll. Nutr. 5, 183-211. (Pubitemid 16083228)
34. Igarashi M., Gao F., Kim H. W., Ma K., Bell J. M., and, Rapoport S. I., (2009) Dietary n-6 PUFA deprivation for 15 weeks reduces arachidonic acid concentrations while increasing n-3 PUFA concentrations in organs of post-weaning male rats. Biochim. Biophys. Acta 1791, 132-139.
35. Igarashi M., Ma K., Gao F., Kim H. W., Greenstein D., Rapoport S. I., and, Rao J. S., (2010) Brain lipid concentrations in bipolar disorder. J. Psychiatr. Res. 44, 177-182.
36. Kaddurah-Daouk R., McEvoy J., Baillie R. A., Lee D., Yao J. K., Doraiswamy P. M., and, Krishnan K. R., (2007) Metabolomic mapping of atypical antipsychotic effects in schizophrenia. Mol. Psychiatry 12, 934-945. (Pubitemid 47482696)
37. Kapur S., and, Remington G., (2001) Atypical antipsychotics: new directions and new challenges in the treatment of schizophrenia. Annu. Rev. Med. 52, 503-517. (Pubitemid 32195338)
38. Kessler R. C., Merikangas K. R., and, Wang P. S., (2007) Prevalence, comorbidity, and service utilization for mood disorders in the United States at the beginning of the twenty-first century. Annu. Rev. Clin. Psychol. 3, 137-158. (Pubitemid 46651124)
39. Kim H. W., Rapoport S. I., and, Rao J. S., (2011a) Altered arachidonic acid cascade enzymes in postmortem brain from bipolar disorder patients. Mol. Psychiatry 16, 419-428.
40. Kim H. W., Rao J. S., Rapoport S. I., and, Igarashi M., (2011b) Dietary n-6 PUFA deprivation downregulates arachidonate but upregulates docosahexaenoate metabolizing enzymes in rat brain. Biochim. Biophys. Acta 1811, 111-117.
41. Lalovic A., Levy E., Canetti L., Sequeira A., Montoudis A., and, Turecki G., (2007) Fatty acid composition in postmortem brains of people who completed suicide. J. Psychiatry Neurosci. 32, 363-370. (Pubitemid 47492761)
42. Lee H. J., Ghelardoni S., Chang L., Bosetti F., Rapoport S. I., and, Bazinet R. P., (2005) Topiramate does not alter the kinetics of arachidonic or docosahexaenoic acid in brain phospholipids of the unanesthetized rat. Neurochem. Res. 30, 677-683. (Pubitemid 41199686)
43. Lee H. J., Rao J. S., Ertley R. N., Chang L., Rapoport S. I., and, Bazinet R. P., (2007a) Chronic fluoxetine increases cytosolic phospholipase A(2) activity and arachidonic acid turnover in brain phospholipids of the unanesthetized rat. Psychopharmacology (Berl) 190, 103-115. (Pubitemid 44885349)
44. Lee H. J., Rao J. S., Rapoport S. I., and, Bazinet R. P., (2007b) Antimanic therapies target brain arachidonic acid signaling: lessons learned about the regulation of brain fatty acid metabolism. Prostaglandins Leukot. Essent. Fatty Acids 77, 239-246. (Pubitemid 350198854)
45. Lee H. J., Rao J. S., Chang L., Rapoport S. I., and, Bazinet R. P., (2008) Chronic N-methyl-d-aspartate administration increases the turnover of arachidonic acid within brain phospholipids of the unanesthetized rat. J. Lipid Res. 49, 162-168.
46. Lee H. J., Rao J. S., Chang L., Rapoport S. I., and, Kim H. W., (2010) Chronic imipramine but not bupropion increases arachidonic acid signaling in rat brain: is this related to 'switching' in bipolar disorder? Mol. Psychiatry 15, 602-614.
47. Livak K. J., and, Schmittgen T. D., (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25, 402-408. (Pubitemid 34164012)
48. Lucas K. K., and, Dennis E. A., (2005) Distinguishing phospholipase A2 types in biological samples by employing group-specific assays in the presence of inhibitors. Prostaglandins Other Lipid Mediat. 77, 235-248. (Pubitemid 41133432)
49. Makrides M., Neumann M. A., Byard R. W., Simmer K., and, Gibson R. A., (1994) Fatty acid composition of brain, retina, and erythrocytes in breast- and formula-fed infants. Am. J. Clin. Nutr. 60, 189-194. (Pubitemid 24233184)
50. McNamara R. K., Jandacek R., Rider T., Tso P., Stanford K. E., Hahn C. G., and, Richtand N. M., (2008) Deficits in docosahexaenoic acid and associated elevations in the metabolism of arachidonic acid and saturated fatty acids in the postmortem orbitofrontal cortex of patients with bipolar disorder. Psychiatry Res. 160, 285-299.
51. McNamara R. K., Jandacek R., Rider T., Tso P., Cole-Strauss A., and, Lipton J. W., (2011a) Atypical antipsychotic medications increase postprandial triglyceride and glucose levels in male rats: relationship with stearoyl-CoA desaturase activity. Schizophr. Res. 129, 66-73.
52. McNamara R. K., Jandacek R., Rider T., Tso P., Cole-Strauss A., and, Lipton J. W., (2011b) Differential effects of antipsychotic medications on polyunsaturated fatty acid biosynthesis in rats: Relationship with liver delta6-desaturase expression. Schizophr. Res. 129, 57-65.
53. Minet-Ringuet J., Even P. C., Valet P., et al. (2007) Alterations of lipid metabolism and gene expression in rat adipocytes during chronic olanzapine treatment. Mol. Psychiatry 12, 562-571. (Pubitemid 46816768)
54. Noaghiul S., and, Hibbeln J. R., (2003) Cross-national comparisons of seafood consumption and rates of bipolar disorders. Am. J. Psychiatry 160, 2222-2227. (Pubitemid 39619617)
55. Oruch R., Pryme I. F., and, Holmsen H., (2008) Effects of psychotropic drugs on the thrombin-induced liberation of arachidonate in human platelets. Saudi Med. J. 29, 1397-1407.
56. Pramyothin P., and, Khaodhiar L., (2010) Metabolic syndrome with the atypical antipsychotics. Curr. Opin. Endocrinol. Diabetes Obes. 17, 460-466.
57. Purdon D., Arai T., and, Rapoport S., (1997) No evidence for direct incorporation of esterified palmitic acid from plasma into brain lipids of awake adult rat. J. Lipid Res. 38, 526-530. (Pubitemid 27166695)
58. Qu Y., Chang L., Klaff J., Balbo A., and, Rapoport S. I., (2003) Imaging brain phospholipase A2 activation in awake rats in response to the 5-HT2A/2C agonist (+/-)2,5-dimethoxy-4-iodophenyl-2-aminopropane (DOI). Neuropsychopharmacology 28, 244-252.
59. Radin N. S., (1981) Extraction of tissue lipids with a solvent of low toxicity. Methods Enzymol. 72, 5-7.
60. Rao J. S., Ertley R. N., DeMar J. C. Jr, Rapoport S. I., Bazinet R. P., and, Lee H. J., (2007a) Dietary n-3 PUFA deprivation alters expression of enzymes of the arachidonic and docosahexaenoic acid cascades in rat frontal cortex. Mol. Psychiatry 12, 151-157. (Pubitemid 46160980)
61. Rao J. S., Ertley R. N., Rapoport S. I., Bazinet R. P., and, Lee H. J., (2007b) Chronic NMDA administration to rats up-regulates frontal cortex cytosolic phospholipase A2 and its transcription factor, activator protein-2. J. Neurochem. 102, 1918-1927. (Pubitemid 47329252)
62. Rao J. S., Lee H. J., Rapoport S. I., and, Bazinet R. P., (2008) Mode of action of mood stabilizers: is the arachidonic acid cascade a common target? Mol. Psychiatry 13, 585-596. (Pubitemid 351704942)
63. Rao J. S., Harry G. J., Rapoport S. I., and, Kim H. W., (2010) Increased excitotoxicity and neuroinflammatory markers in postmortem frontal cortex from bipolar disorder patients. Mol. Psychiatry 15, 384-392.
64. Rapoport S. I., (2008) Arachidonic acid and the brain. J. Nutr. 138, 2515-2520.
65. Rapoport S. I., and, Bosetti F., (2002) Do lithium and anticonvulsants target the brain arachidonic acid cascade in bipolar disorder? Arch. Gen. Psychiatry 59, 592-596. (Pubitemid 34747238)
66. Rapoport S. I., Chang M. C., and, Spector A. A., (2001) Delivery and turnover of plasma-derived essential PUFAs in mammalian brain. J. Lipid Res. 42, 678-685. (Pubitemid 32507167)
67. Rapoport S. I., Rao J. S., and, Igarashi M., (2007) Brain metabolism of nutritionally essential polyunsaturated fatty acids depends on both the diet and the liver. Prostaglandins Leukot. Essent. Fatty Acids 77, 251-261. (Pubitemid 350214520)
68. Rapoport S. I., Basselin M., Kim H. W., and, Rao J. S., (2009) Bipolar disorder and mechanisms of action of mood stabilizers. Brain Res. Rev. 61, 185-209.
69. Rintala J., Seemann R., Chandrasekaran K., Rosenberger T. A., Chang L., Contreras M. A., Rapoport S. I., and, Chang M. C., (1999) 85 kDa cytosolic phospholipase A2 is a target for chronic lithium in rat brain. Neuroreport 10, 3887-3890. (Pubitemid 30004851)
70. Robinson P. J., Noronha J., DeGeorge J. J., Freed L. M., Nariai T., and, Rapoport S. I., (1992) A quantitative method for measuring regional in vivo fatty-acid incorporation into and turnover within brain phospholipids: review and critical analysis. Brain Res. Brain Res. Rev. 17, 187-214.
71. Samuelsson B., Dahlen S. E., Lindgren J. A., Rouzer C. A., and, Serhan C. N., (1987) Leukotrienes and lipoxins: structures, biosynthesis, and biological effects. Science 237, 1171-1176. (Pubitemid 17131222)
72. Scherk H., Pajonk F. G., and, Leucht S., (2007) Second-generation antipsychotic agents in the treatment of acute mania: a systematic review and meta-analysis of randomized controlled trials. Arch. Gen. Psychiatry 64, 442-455. (Pubitemid 46556468)
73. Shimshoni J. A., Basselin M., Li L. O., Coleman R. A., Rapoport S. I., and, Modi H. R., (2011) Valproate uncompetitively inhibits arachidonic acid acylation by rat acyl-CoA synthetase 4: Relevance to valproate's efficacy against bipolar disorder. Biochim. Biophys. Acta 1811, 163-169.
74. Skipski V. P., Barclay M., Reichman E. S., and, Good J. J., (1967) Separation of acidic phospholipids by one-dimensional thin-layer chromatography. Biochim. Biophys. Acta 137, 80-89.
75. Skipski V. P., Good J. J., Barclay M., and, Reggio R. B., (1968) Quantitative analysis of simple lipid classes by thin-layer chromatography. Biochim. Biophys. Acta 152, 10-19.
76. Song C., and, Nerdal W., (2008) Olanzapine interaction with dipalmitoyl phosphatidylcholine (DPPC) and 1-palmitoyl-2-oleoyl phosphatidylserine (POPS) bilayer: a (13)C and (31)P solid-state NMR study. Biophys. Chem. 134, 47-55.
77. Spector A. A., (2009) Arachidonic acid cytochrome P450 epoxygenase pathway. J. Lipid Res. 50 Suppl, S52-S56.
78. Steinkopf S., Schelderup A. K., Gjerde H. L., Pfeiffer J., Thoresen S., Gjerde A. U., and, Holmsen H., (2008) The psychotropic drug olanzapine (Zyprexa) increases the area of acid glycerophospholipid monolayers. Biophys. Chem. 134, 39-46.
79. Stoll A. L., Severus W. E., Freeman M. P., Rueter S., Zboyan H. A., Diamond E., Cress K. K., and, Marangell L. B., (1999) Omega 3 fatty acids in bipolar disorder: a preliminary double-blind, placebo-controlled trial. Arch. Gen. Psychiatry 56, 407-412. (Pubitemid 29215428)
80. Svennerholm L., Bostrom K., and, Jungbjer B., (1997) Changes in weight and compositions of major membrane components of human brain during the span of adult human life of Swedes. Acta Neuropathol. 94, 345-352. (Pubitemid 27450114)
81. Vial D., and, Piomelli D., (1995) Dopamine D2 receptors potentiate arachidonate release via activation of cytosolic, arachidonate-specific phospholipase A2. J. Neurochem. 64, 2765-2772.
82. Vidarsdottir S., de Leeuw van Weenen J. E., Frolich M., Roelfsema F., Romijn J. A., and, Pijl H., (2010) Effects of olanzapine and haloperidol on the metabolic status of healthy men. J. Clin. Endocrinol. Metab. 95, 118-125.
83. Washizaki K., Smith Q. R., Rapoport S. I., and, Purdon A. D., (1994) Brain arachidonic acid incorporation and precursor pool specific activity during intravenous infusion of unesterified [3H]arachidonate in the anesthetized rat. J. Neurochem. 63, 727-736. (Pubitemid 24233711)
84. Waugh R. J., Morrow J. D., Roberts 2nd L. J., and, Murphy R. C., (1997) Identification and relative quantitation of F2-isoprostane regioisomers formed in vivo in the rat. Free Radic. Biol. Med., 23, 943-954. (Pubitemid 27402620)
85. Weerasinghe G. R., Rapoport S. I., and, Bosetti F., (2004) The effect of chronic lithium on arachidonic acid release and metabolism in rat brain does not involve secretory phospholipase A2 or lipoxygenase/cytochrome P450 pathways. Brain Res. Bull. 63, 485-489. (Pubitemid 38891858)
86. Yang H. C., Mosior M., Johnson C. A., Chen Y., and, Dennis E. A., (1999) Group-specific assays that distinguish between the four major types of mammalian phospholipase A2. Anal. Biochem. 269, 278-288. (Pubitemid 29201025)